(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:70824 6480464 epigallocatechin gallate inhibits the reaction [HGF protein results in increased phosphorylation of MET protein] CTD PMID:19244381 (1->4)-beta-D-glucan multiple interactions ISO RGD:10894 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MET mRNA CTD PMID:36331819 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:70824 6480464 o, p'-DDT results in increased expression of MET mRNA CTD PMID:19371625 1,1-dichloroethene decreases expression ISO RGD:10894 6480464 vinylidene chloride results in decreased expression of MET mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:10894 6480464 1, 2-Dimethylhydrazine results in decreased expression of MET mRNA CTD PMID:26388957 1,2-dimethylhydrazine affects expression ISO RGD:10894 6480464 1, 2-Dimethylhydrazine affects the expression of MET mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of MET mRNA CTD PMID:32387197 1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester increases expression ISO RGD:70824 6480464 carbetapentane results in increased expression of MET mRNA CTD PMID:32816093 17beta-estradiol increases expression ISO RGD:70824 6480464 Estradiol results in increased expression of MET mRNA CTD PMID:23019147 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of MET mRNA CTD PMID:32145629 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of MET mRNA CTD PMID:31119341 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Testosterone] results in increased expression of MET mRNA CTD PMID:11375906 17beta-estradiol increases expression ISO RGD:10894 6480464 Estradiol results in increased expression of MET mRNA CTD PMID:17640349 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:70824 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:70824 6480464 2 more ... CTD PMID:23146750 2,3,3',4,4',5,5'-Heptachlorobiphenyl decreases expression ISO RGD:70824 6480464 2 more ... CTD PMID:26238599 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10894 6480464 Tetrachlorodibenzodioxin results in decreased expression of MET mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MET mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MET mRNA CTD PMID:20959002 , PMID:21215274 2-amino-2-deoxy-D-galactopyranose multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of MET mRNA], [Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of MET mRNA CTD PMID:28844859 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO RGD:10894 6480464 [Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of MET mRNA CTD PMID:28887131 2-hydroxypropanoic acid increases expression ISO RGD:70824 6480464 Lactic Acid results in increased expression of MET mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:70824 6480464 3 more ... CTD PMID:23146750 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3-Nitrobenzanthrone increases expression ISO RGD:70824 6480464 3-nitrobenzanthrone results in increased expression of MET mRNA, 3-nitrobenzanthrone results in increased expression of MET protein CTD PMID:34036453 4,4'-sulfonyldiphenol increases expression ISO RGD:10894 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MET mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO RGD:10894 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of MET exon CTD PMID:33297965 4-aminosalicylic acid increases expression ISO RGD:70824 6480464 Aminosalicylic Acid results in increased expression of MET mRNA CTD PMID:32816093 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of MET mRNA] CTD PMID:28844859 5-aza-2'-deoxycytidine multiple interactions ISO RGD:70824 6480464 TP53 protein affects the reaction [Decitabine results in decreased expression of MET mRNA] CTD PMID:19363521 5-aza-2'-deoxycytidine decreases expression ISO RGD:70824 6480464 Decitabine results in decreased expression of MET mRNA CTD PMID:19363521 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MET mRNA CTD PMID:24780913 6alpha-methylprednisolone decreases expression ISO RGD:70824 6480464 Methylprednisolone results in decreased expression of MET mRNA CTD PMID:19192274 9-cis-retinoic acid increases phosphorylation ISO RGD:70824 6480464 Alitretinoin results in increased phosphorylation of MET protein CTD PMID:16192631 ABT-737 multiple interactions ISO RGD:70824 6480464 ABT-737 inhibits the reaction [[MET protein affects the susceptibility to HGF protein] affects the reaction [BRAF protein mutant form results in increased susceptibility to Vemurafenib]] CTD PMID:27689874 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of MET mRNA CTD PMID:31881176 acetic acid multiple interactions EXP 6480464 Celecoxib inhibits the reaction [Acetic Acid results in increased expression of MET mRNA], Celecoxib inhibits the reaction [Acetic Acid results in increased expression of MET protein] CTD PMID:11891194 acetic acid increases expression EXP 6480464 Acetic Acid results in increased expression of MET mRNA, Acetic Acid results in increased expression of MET protein CTD PMID:11891194 acetylsalicylic acid multiple interactions ISO RGD:70824 6480464 CTNNB1 affects the reaction [Aspirin results in decreased expression of CMET protein] CTD PMID:16878161 acetylsalicylic acid increases expression ISO RGD:70824 6480464 Aspirin results in increased expression of MET mRNA CTD PMID:32816093 acetylsalicylic acid decreases expression ISO RGD:70824 6480464 Aspirin results in decreased expression of CMET protein CTD PMID:16878161 acrylamide decreases expression ISO RGD:10894 6480464 Acrylamide results in decreased expression of MET mRNA CTD PMID:30807115 afimoxifene decreases expression ISO RGD:10894 6480464 afimoxifene results in decreased expression of MET mRNA CTD PMID:17640349 aflatoxin B1 decreases methylation ISO RGD:70824 6480464 Aflatoxin B1 results in decreased methylation of MET gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of MET mRNA CTD PMID:33354967 aflatoxin B1 decreases expression ISO RGD:70824 6480464 Aflatoxin B1 results in decreased expression of MET mRNA CTD PMID:28943387 all-trans-retinoic acid increases expression ISO RGD:70824 6480464 Tretinoin results in increased expression of MET mRNA, Tretinoin results in increased expression of MET protein CTD PMID:15914280 more ... all-trans-retinoic acid multiple interactions ISO RGD:70824 6480464 Tretinoin inhibits the reaction [HGF protein results in increased expression of MET protein] CTD PMID:9932610 all-trans-retinoic acid decreases expression ISO RGD:70824 6480464 Tretinoin results in decreased expression of MET protein CTD PMID:9932610 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MET mRNA CTD PMID:16483693 amodiaquine increases expression ISO RGD:70824 6480464 Amodiaquine results in increased expression of MET mRNA CTD PMID:32816093 apigenin decreases phosphorylation ISO RGD:70824 6480464 Apigenin results in decreased phosphorylation of MET protein CTD PMID:27468969 aristolochic acid A decreases expression ISO RGD:70824 6480464 aristolochic acid I results in decreased expression of MET mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:70824 6480464 arsenite inhibits the reaction [G3BP1 protein binds to MET mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:70824 6480464 Arsenic Trioxide results in decreased expression of MET mRNA CTD PMID:19769630 , PMID:20458559 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of MET gene CTD PMID:35440735 azathioprine decreases expression ISO RGD:70824 6480464 Azathioprine results in decreased expression of MET mRNA CTD PMID:19192274 benzatropine increases expression ISO RGD:70824 6480464 Benztropine results in increased expression of MET mRNA CTD PMID:32816093 benzo[a]pyrene decreases expression ISO RGD:70824 6480464 Benzo(a)pyrene results in decreased expression of MET mRNA CTD PMID:20889680 benzo[a]pyrene increases expression ISO RGD:70824 6480464 Benzo(a)pyrene results in increased expression of MET mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:70824 6480464 Benzo(a)pyrene results in decreased methylation of MET 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:10894 6480464 Benzo(a)pyrene results in decreased methylation of MET intron CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:10894 6480464 Benzo(a)pyrene results in decreased expression of MET mRNA, Benzo(a)pyrene results in decreased expression of MET protein CTD PMID:20889680 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:70824 6480464 7 more ... CTD PMID:19150397 bicalutamide multiple interactions ISO RGD:10894 6480464 bicalutamide inhibits the reaction [Testosterone results in increased expression of MET mRNA] CTD PMID:11139396 , PMID:17371283 bilirubin IXalpha increases secretion ISO RGD:10894 6480464 MET gene mutant form results in increased secretion of Bilirubin CTD PMID:27394961 biperiden increases expression ISO RGD:70824 6480464 Biperiden results in increased expression of MET mRNA CTD PMID:32816093 bis(2-ethylhexyl) phthalate increases expression ISO RGD:70824 6480464 Diethylhexyl Phthalate results in increased expression of MET mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:70824 6480464 bisphenol A results in increased expression of MET mRNA CTD PMID:19371625 bisphenol A decreases expression ISO RGD:10894 6480464 bisphenol A results in decreased expression of MET mRNA CTD PMID:32365465 bisphenol A increases methylation ISO RGD:70824 6480464 bisphenol A results in increased methylation of MET gene CTD PMID:31601247 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MET mRNA CTD PMID:32145629 bisphenol A increases expression ISO RGD:10894 6480464 bisphenol A results in increased expression of MET mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MET mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of MET mRNA CTD PMID:25607892 bisphenol F increases expression ISO RGD:10894 6480464 bisphenol F results in increased expression of MET mRNA CTD PMID:30951980 bromfenac increases expression ISO RGD:70824 6480464 bromfenac results in increased expression of MET mRNA CTD PMID:32816093 Butylparaben multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of MET mRNA CTD PMID:25607892 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of MET mRNA CTD PMID:19167457 cabozantinib decreases phosphorylation ISO RGD:70824 6480464 cabozantinib results in decreased phosphorylation of MET protein CTD PMID:31639374 cadmium atom increases expression ISO RGD:70824 6480464 Cadmium results in increased expression of MET mRNA CTD PMID:22562489 cadmium atom increases activity ISO RGD:70824 6480464 Cadmium results in increased activity of MET protein CTD PMID:25343777 cadmium atom multiple interactions ISO RGD:70824 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased ubiquitination of MET protein CTD PMID:33040242 cadmium dichloride decreases expression ISO RGD:70824 6480464 Cadmium Chloride results in decreased expression of MET mRNA CTD PMID:12160620 cadmium dichloride multiple interactions ISO RGD:70824 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased ubiquitination of MET protein CTD PMID:33040242 caffeine decreases phosphorylation ISO RGD:70824 6480464 Caffeine results in decreased phosphorylation of MET protein CTD PMID:35688186 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of MET mRNA CTD PMID:18172885 celecoxib multiple interactions EXP 6480464 Celecoxib inhibits the reaction [Acetic Acid results in increased expression of MET mRNA], Celecoxib inhibits the reaction [Acetic Acid results in increased expression of MET protein] CTD PMID:11891194 CGP 52608 multiple interactions ISO RGD:70824 6480464 CGP 52608 promotes the reaction [RORA protein binds to MET gene] CTD PMID:28238834 choline multiple interactions ISO RGD:10894 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MET mRNA CTD PMID:20938992 cisplatin multiple interactions ISO RGD:70824 6480464 Cisplatin promotes the reaction [5-((2 more ... CTD PMID:20661229 cisplatin increases expression ISO RGD:10894 6480464 Cisplatin results in increased expression of MET mRNA CTD PMID:21151649 cisplatin decreases phosphorylation ISO RGD:70824 6480464 Cisplatin results in decreased phosphorylation of MET protein CTD PMID:20661229 clavulanic acid increases expression ISO RGD:70824 6480464 Clavulanic Acid results in increased expression of MET mRNA CTD PMID:32816093 clofarabine multiple interactions ISO RGD:70824 6480464 [resveratrol co-treated with clofarabine] results in decreased expression of MET protein CTD PMID:23146690 cobalt atom multiple interactions ISO RGD:70824 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of MET mRNA CTD PMID:18078969 cobalt dichloride increases expression ISO RGD:70824 6480464 cobaltous chloride results in increased expression of MET mRNA CTD PMID:19376846 cocaine affects expression ISO RGD:10894 6480464 Cocaine affects the expression of MET mRNA CTD PMID:15681117 copper atom multiple interactions ISO RGD:70824 6480464 [Chelating Agents binds to Copper] which affects the expression of MET mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:70824 6480464 [Chelating Agents binds to Copper] which affects the expression of MET mRNA CTD PMID:30911355 coumarin increases phosphorylation ISO RGD:70824 6480464 coumarin results in increased phosphorylation of MET protein CTD PMID:35688186 crizotinib decreases activity ISO RGD:70824 6480464 crizotinib results in decreased activity of MET protein CTD PMID:21405128 more ... crizotinib affects response to substance ISO RGD:70824 6480464 MET protein affects the susceptibility to Crizotinib CTD PMID:31706006 crizotinib increases mutagenesis ISO RGD:70824 6480464 crizotinib results in increased mutagenesis of MET protein CTD PMID:21266357 crizotinib increases response to substance ISO RGD:70824 6480464 MET gene mutant form results in increased susceptibility to crizotinib CTD PMID:22729845 crizotinib multiple interactions ISO RGD:70824 6480464 [5-((2 more ... CTD PMID:21266357 more ... crizotinib decreases phosphorylation ISO RGD:70824 6480464 Crizotinib results in decreased phosphorylation of MET protein CTD PMID:22233293 more ... crocidolite asbestos multiple interactions ISO RGD:70824 6480464 FOSL1 protein promotes the reaction [Asbestos, Crocidolite results in increased expression of MET mRNA] CTD PMID:12839939 crocidolite asbestos multiple interactions EXP 6480464 FOSL1 protein promotes the reaction [Asbestos, Crocidolite results in increased expression of MET mRNA] CTD PMID:12839939 crocidolite asbestos increases expression ISO RGD:70824 6480464 Asbestos, Crocidolite results in increased expression of MET mRNA CTD PMID:12839939 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of MET mRNA CTD PMID:12839939 cyclosporin A increases expression ISO RGD:70824 6480464 Cyclosporine results in increased expression of MET mRNA CTD PMID:27989131 cyproconazole decreases expression ISO RGD:70824 6480464 cyproconazole results in decreased expression of MET mRNA CTD PMID:26238599 DDT increases phosphorylation ISO RGD:70824 6480464 DDT results in increased phosphorylation of MET protein CTD PMID:9070211 deoxynivalenol affects phosphorylation ISO RGD:10894 6480464 deoxynivalenol affects the phosphorylation of MET protein CTD PMID:23811945 diarsenic trioxide decreases expression ISO RGD:70824 6480464 Arsenic Trioxide results in decreased expression of MET mRNA CTD PMID:19769630 , PMID:20458559 diazinon affects expression EXP 6480464 Diazinon affects the expression of MET mRNA CTD PMID:22546817 Dibromoacetonitrile increases expression EXP 6480464 dibromoacetonitrile results in increased expression of MET mRNA CTD PMID:21986297 diclofenac decreases expression ISO RGD:70824 6480464 Diclofenac results in decreased expression of MET mRNA CTD PMID:19192274 diclofenac increases expression ISO RGD:70824 6480464 Diclofenac results in increased expression of MET mRNA CTD PMID:32816093 Dictamnine decreases expression ISO RGD:70824 6480464 dictamnine results in decreased expression of MET mRNA CTD PMID:34861243 Dictamnine decreases phosphorylation ISO RGD:70824 6480464 dictamnine results in decreased phosphorylation of MET protein CTD PMID:34861243 Dictamnine affects binding ISO RGD:70824 6480464 dictamnine binds to MET protein CTD PMID:34861243 Dictamnine multiple interactions ISO RGD:70824 6480464 dictamnine inhibits the reaction [FGF protein results in increased phosphorylation of MET protein] CTD PMID:34861243 diethylstilbestrol increases expression ISO RGD:70824 6480464 Diethylstilbestrol results in increased expression of MET mRNA CTD PMID:19371625 dioxygen multiple interactions ISO RGD:10894 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MET mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:70824 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:10894 6480464 Doxorubicin results in decreased expression of MET protein CTD PMID:16109756 , PMID:18083897 doxorubicin decreases expression ISO RGD:70824 6480464 Doxorubicin results in decreased expression of MET mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:10894 6480464 HGF protein inhibits the reaction [Doxorubicin results in decreased expression of MET protein] CTD PMID:16109756 , PMID:18083897 entacapone increases expression ISO RGD:70824 6480464 entacapone results in increased expression of MET mRNA CTD PMID:32816093 enzacamene multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of MET mRNA CTD PMID:25607892 erlotinib hydrochloride multiple interactions ISO RGD:70824 6480464 [Erlotinib Hydrochloride co-treated with Dasatinib] results in decreased phosphorylation of MET protein CTD PMID:21106725 erlotinib hydrochloride decreases phosphorylation ISO RGD:70824 6480464 Erlotinib Hydrochloride results in decreased phosphorylation of MET protein CTD PMID:21106725 , PMID:23894143 esmolol increases expression ISO RGD:70824 6480464 esmolol results in increased expression of MET mRNA CTD PMID:32816093 ethambutol increases expression ISO RGD:70824 6480464 Ethambutol results in increased expression of MET mRNA CTD PMID:32816093 ethanol increases expression EXP 6480464 Ethanol results in increased expression of MET mRNA CTD PMID:15353170 , PMID:16946407 ethanol increases expression ISO RGD:10894 6480464 Ethanol results in increased expression of MET mRNA CTD PMID:35149083 etodolac increases expression ISO RGD:70824 6480464 Etodolac results in increased expression of MET mRNA CTD PMID:32816093 Fexofenadine hydrochloride decreases expression ISO RGD:70824 6480464 fexofenadine results in decreased expression of MET mRNA CTD PMID:32816093 fludrocortisone increases expression ISO RGD:70824 6480464 Fludrocortisone results in increased expression of MET mRNA CTD PMID:32816093 flutamide increases expression ISO RGD:70824 6480464 Flutamide results in increased expression of MET mRNA CTD PMID:32816093 folic acid multiple interactions ISO RGD:10894 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MET mRNA more ... CTD PMID:11139396 , PMID:20938992 folic acid increases expression ISO RGD:10894 6480464 Folic Acid results in increased expression of MET mRNA CTD PMID:11139396 furan increases methylation EXP 6480464 furan results in increased methylation of MET gene CTD PMID:22079235 gallic acid decreases expression ISO RGD:70824 6480464 Gallic Acid results in decreased expression of MET mRNA CTD PMID:34408198 geldanamycin increases expression ISO RGD:70824 6480464 geldanamycin results in increased expression of MET mRNA CTD PMID:26705709 genistein increases expression ISO RGD:70824 6480464 Genistein results in increased expression of MET mRNA CTD PMID:19371625 ginsenoside Rg1 multiple interactions ISO RGD:70824 6480464 Mifepristone inhibits the reaction [ginsenoside Rg1 results in increased expression of MET protein], MIR23A mRNA inhibits the reaction [ginsenoside Rg1 results in increased expression of MET protein] CTD PMID:26115870 ginsenoside Rg1 increases expression ISO RGD:70824 6480464 ginsenoside Rg1 results in increased expression of MET protein CTD PMID:26115870 glutathione multiple interactions ISO RGD:10894 6480464 MET gene mutant form promotes the reaction [[Cholesterol, Dietary co-treated with Sodium Cholate] results in increased oxidation of Glutathione] CTD PMID:27394961 graphite affects expression EXP 6480464 Graphite affects the expression of MET mRNA CTD PMID:29933104 heparin multiple interactions ISO RGD:70824 6480464 Heparin promotes the reaction [HGF protein binds to and results in increased activity of MET protein] CTD PMID:9083085 hexadecanoic acid multiple interactions ISO RGD:70824 6480464 Palmitic Acid inhibits the reaction [Quercetin results in decreased expression of MET protein] CTD PMID:25971889 Iproniazid increases expression ISO RGD:70824 6480464 Iproniazid results in increased expression of MET mRNA CTD PMID:32816093 ivermectin decreases expression ISO RGD:70824 6480464 Ivermectin results in decreased expression of MET protein CTD PMID:32959892 kaempferol multiple interactions ISO RGD:70824 6480464 kaempferol inhibits the reaction [HGF protein results in increased phosphorylation of MET protein] CTD PMID:19244381 ketoconazole increases expression ISO RGD:70824 6480464 Ketoconazole results in increased expression of MET mRNA CTD PMID:32816093 L-ascorbic acid decreases expression ISO RGD:70824 6480464 Ascorbic Acid results in decreased expression of MET mRNA CTD PMID:21919647 L-methionine multiple interactions ISO RGD:10894 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MET mRNA CTD PMID:20938992 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of MET protein CTD PMID:17298174 lead nitrate multiple interactions ISO RGD:10894 6480464 lead nitrate affects the reaction [MET affects the expression of MT1 mRNA], lead nitrate affects the reaction [MET affects the expression of MT2 mRNA] CTD PMID:11891201 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of MET protein CTD PMID:17298174 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of MET mRNA CTD PMID:24136188 licocoumarone decreases expression ISO RGD:70824 6480464 licocoumarone results in decreased expression of MET protein CTD PMID:31838052 lipopolysaccharide multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of MET mRNA], [Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of MET mRNA CTD PMID:28844859 lipopolysaccharide multiple interactions ISO RGD:70824 6480464 Lipopolysaccharides promotes the reaction [Propofol results in increased expression of MET mRNA] more ... CTD PMID:35811015 , PMID:35953652 lipopolysaccharide increases expression ISO RGD:70824 6480464 Lipopolysaccharides results in increased expression of MET mRNA CTD PMID:35811015 , PMID:35953652 lumiracoxib increases expression ISO RGD:70824 6480464 lumiracoxib results in increased expression of MET mRNA CTD PMID:32816093 malathion increases expression ISO RGD:70824 6480464 Malathion results in increased expression of MET mRNA CTD PMID:37047231 malonaldehyde multiple interactions ISO RGD:70824 6480464 [AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Malondialdehyde, Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in increased abundance of Malondialdehyde] CTD PMID:32045588 mebendazole increases expression ISO RGD:70824 6480464 Mebendazole results in increased expression of MET mRNA CTD PMID:32816093 menadione increases expression ISO RGD:10894 6480464 Vitamin K 3 results in increased expression of MET mRNA CTD PMID:25270620 methotrexate increases expression ISO RGD:70824 6480464 Methotrexate results in increased expression of MET mRNA CTD PMID:21678067 methotrexate decreases expression ISO RGD:70824 6480464 Methotrexate results in decreased expression of MET mRNA CTD PMID:19192274 methyltestosterone multiple interactions ISO RGD:70824 6480464 [Methyltestosterone co-treated with Cholic Acids] affects the expression of MET mRNA CTD PMID:27344345 microcystin-LR increases expression ISO RGD:70824 6480464 cyanoginosin LR results in increased expression of MET mRNA, cyanoginosin LR results in increased expression of MET protein CTD PMID:28062358 mifepristone multiple interactions ISO RGD:70824 6480464 Mifepristone inhibits the reaction [ginsenoside Rg1 results in increased expression of MET protein] CTD PMID:26115870 minoxidil decreases expression ISO RGD:70824 6480464 Minoxidil results in decreased expression of MET mRNA CTD PMID:32816093 myricetin multiple interactions ISO RGD:70824 6480464 myricetin inhibits the reaction [HGF protein results in increased phosphorylation of MET protein] CTD PMID:19244381 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:70824 6480464 Methylnitronitrosoguanidine results in increased expression of MET mRNA CTD PMID:12634122 N-nitrosodiethylamine multiple interactions ISO RGD:10894 6480464 CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of MET protein] more ... CTD PMID:17942915 , PMID:20583210 N-nitrosodiethylamine affects response to substance EXP 6480464 MET affects the susceptibility to Diethylnitrosamine CTD PMID:19123478 N-nitrosodiethylamine increases response to substance ISO RGD:10894 6480464 MET protein results in increased susceptibility to Diethylnitrosamine CTD PMID:17942915 N-nitrosodiethylamine decreases expression ISO RGD:10894 6480464 Diethylnitrosamine results in decreased expression of MET protein CTD PMID:20583210 N-nitrosodimethylamine affects expression EXP 6480464 Dimethylnitrosamine affects the expression of MET mRNA CTD PMID:16596271 nefazodone increases expression ISO RGD:70824 6480464 nefazodone results in increased expression of MET mRNA CTD PMID:32816093 nevirapine increases expression ISO RGD:70824 6480464 Nevirapine results in increased expression of MET mRNA CTD PMID:32816093 niclosamide decreases expression EXP 6480464 Niclosamide results in decreased expression of MET mRNA CTD PMID:27338550 nimesulide increases expression ISO RGD:70824 6480464 nimesulide results in increased expression of MET mRNA CTD PMID:32816093 nomifensine decreases expression ISO RGD:70824 6480464 Nomifensine results in decreased expression of MET mRNA CTD PMID:32816093 ochratoxin A multiple interactions ISO RGD:70824 6480464 5-((2 more ... CTD PMID:25002221 oleanolic acid decreases expression ISO RGD:70824 6480464 Oleanolic Acid results in decreased expression of MET protein CTD PMID:20726234 orlistat multiple interactions ISO RGD:70824 6480464 Orlistat inhibits the reaction [[AKT1 gene mutant form co-treated with MET gene mutant form] results in decreased expression of PTEN protein] more ... CTD PMID:32045588 osimertinib multiple interactions ISO RGD:70824 6480464 osimertinib results in decreased expression of and results in decreased phosphorylation of MET protein CTD PMID:34861243 oxybutynin decreases expression ISO RGD:70824 6480464 oxybutynin results in decreased expression of MET mRNA CTD PMID:32816093 paracetamol decreases expression ISO RGD:70824 6480464 Acetaminophen results in decreased expression of MET mRNA CTD PMID:21420995 paracetamol decreases expression ISO RGD:10894 6480464 Acetaminophen results in decreased expression of MET mRNA CTD PMID:17585979 paracetamol affects expression ISO RGD:10894 6480464 Acetaminophen affects the expression of MET mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:70824 6480464 Acetaminophen results in increased expression of MET mRNA CTD PMID:22230336 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of MET mRNA, Paraquat results in decreased expression of MET protein CTD PMID:17298174 , PMID:32680482 parecoxib decreases expression ISO RGD:70824 6480464 parecoxib results in decreased expression of MET protein CTD PMID:35917206 PCB138 affects expression ISO RGD:70824 6480464 2 more ... CTD PMID:21703328 PD173074 multiple interactions ISO RGD:70824 6480464 [PD 173074 results in decreased activity of FGFR1 protein] inhibits the reaction [[crizotinib results in decreased phosphorylation of MET protein] which results in increased expression of HGF protein] CTD PMID:22683780 penbutolol increases expression ISO RGD:70824 6480464 Penbutolol results in increased expression of MET mRNA CTD PMID:32816093 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10894 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MET mRNA CTD PMID:36331819 PHA-665752 increases mutagenesis ISO RGD:70824 6480464 5-((2 more ... CTD PMID:21266357 PHA-665752 multiple interactions ISO RGD:70824 6480464 5-((2 more ... CTD PMID:20661229 more ... PHA-665752 decreases activity ISO RGD:70824 6480464 5-((2 more ... CTD PMID:21106725 PHA-665752 decreases phosphorylation ISO RGD:70824 6480464 5-((2 more ... CTD PMID:21266357 phenobarbital increases expression ISO RGD:10894 6480464 Phenobarbital results in increased expression of MET mRNA CTD PMID:19270015 , PMID:19363144 Phenoxybenzamine decreases expression ISO RGD:70824 6480464 Phenoxybenzamine results in decreased expression of MET mRNA CTD PMID:32816093 phentolamine decreases expression ISO RGD:70824 6480464 Phentolamine results in decreased expression of MET mRNA CTD PMID:32816093 phenylmercury acetate increases expression ISO RGD:70824 6480464 Phenylmercuric Acetate results in increased expression of MET mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:70824 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MET mRNA CTD PMID:27188386 pioglitazone increases expression ISO RGD:70824 6480464 Pioglitazone results in increased expression of MET mRNA CTD PMID:32816093 piperine affects binding ISO RGD:70824 6480464 piperine binds to MET protein CTD PMID:28341137 pirinixic acid increases expression ISO RGD:10894 6480464 pirinixic acid results in increased expression of MET mRNA CTD PMID:18301758 pirinixic acid decreases expression ISO RGD:10894 6480464 pirinixic acid results in decreased expression of MET mRNA CTD PMID:23811191 piroxicam decreases expression ISO RGD:70824 6480464 Piroxicam results in decreased expression of MET mRNA CTD PMID:19192274 pirprofen increases expression ISO RGD:70824 6480464 pirprofen results in increased expression of MET mRNA CTD PMID:32816093 poly(propylene imine) macromolecule affects expression ISO RGD:70824 6480464 poly(propyleneimine) analog affects the expression of MET mRNA CTD PMID:16308212 potassium dichromate increases expression ISO RGD:10894 6480464 Potassium Dichromate results in increased expression of MET mRNA CTD PMID:23608068 prednisolone decreases expression ISO RGD:70824 6480464 Prednisolone results in decreased expression of MET mRNA CTD PMID:19192274 procyclidine increases expression ISO RGD:70824 6480464 Procyclidine results in increased expression of MET mRNA CTD PMID:32816093 propofol multiple interactions ISO RGD:70824 6480464 Lipopolysaccharides promotes the reaction [Propofol results in increased expression of MET mRNA] CTD PMID:35953652 propofol increases expression ISO RGD:70824 6480464 Propofol results in increased expression of MET mRNA CTD PMID:35953652 protriptyline increases expression ISO RGD:70824 6480464 Protriptyline results in increased expression of MET mRNA CTD PMID:32816093 quercetin multiple interactions ISO RGD:70824 6480464 Palmitic Acid inhibits the reaction [Quercetin results in decreased expression of MET protein] more ... CTD PMID:19244381 , PMID:25971889 quercetin decreases expression ISO RGD:70824 6480464 Quercetin analog results in decreased expression of MET protein more ... CTD PMID:19877526 more ... rac-lactic acid increases expression ISO RGD:70824 6480464 Lactic Acid results in increased expression of MET mRNA CTD PMID:30851411 resveratrol increases expression ISO RGD:70824 6480464 resveratrol results in increased expression of MET mRNA CTD PMID:19371625 resveratrol multiple interactions ISO RGD:70824 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of MET mRNA, [Resveratrol co-treated with Clofarabine] results in decreased expression of MET protein CTD PMID:23146690 , PMID:23557933 retinyl acetate increases expression ISO RGD:10894 6480464 retinol acetate results in increased expression of MET mRNA CTD PMID:16772331 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:70824 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of MET mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:70824 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MET mRNA] CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:70824 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sevoflurane increases expression ISO RGD:70824 6480464 Sevoflurane results in increased expression of MET mRNA CTD PMID:35953652 sevoflurane multiple interactions ISO RGD:70824 6480464 Lipopolysaccharides promotes the reaction [Sevoflurane results in increased expression of MET mRNA] CTD PMID:35953652 sodium arsenite increases phosphorylation ISO RGD:70824 6480464 sodium arsenite results in increased phosphorylation of MET protein CTD PMID:20043101 sodium arsenite decreases expression ISO RGD:70824 6480464 sodium arsenite results in decreased expression of MET mRNA CTD PMID:34032870 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of MET mRNA CTD PMID:11241755 , PMID:16876216 sodium arsenite affects expression ISO RGD:10894 6480464 sodium arsenite affects the expression of MET mRNA CTD PMID:16507464 sodium aurothiomalate decreases expression ISO RGD:70824 6480464 Gold Sodium Thiomalate results in decreased expression of MET mRNA CTD PMID:19192274 sodium cholate multiple interactions ISO RGD:10894 6480464 MET gene mutant form affects the susceptibility to [Cholesterol more ... CTD PMID:27394961 sulindac sulfide multiple interactions ISO RGD:70824 6480464 sulindac sulfide inhibits the reaction [CTNNB1 protein results in increased expression of MET protein] CTD PMID:14710233 sunitinib increases expression ISO RGD:70824 6480464 Sunitinib results in increased expression of MET mRNA CTD PMID:31533062 tanespimycin decreases expression ISO RGD:70824 6480464 tanespimycin results in decreased expression of MET protein CTD PMID:22810956 tanespimycin decreases expression EXP 6480464 tanespimycin results in decreased expression of MET protein CTD PMID:22810956 temozolomide decreases expression ISO RGD:70824 6480464 Temozolomide results in decreased expression of MET mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:70824 6480464 tert-Butylhydroperoxide results in decreased expression of MET mRNA CTD PMID:15336504 testosterone multiple interactions EXP 6480464 [Estradiol co-treated with Testosterone] results in increased expression of MET mRNA CTD PMID:11375906 testosterone multiple interactions ISO RGD:10894 6480464 bicalutamide inhibits the reaction [Testosterone results in increased expression of MET mRNA] more ... CTD PMID:11139396 , PMID:17371283 testosterone increases expression ISO RGD:10894 6480464 Testosterone results in increased expression of MET mRNA CTD PMID:11139396 , PMID:17371283 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MET mRNA CTD PMID:12832660 , PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with TM4SF4 protein] results in decreased expression of MET mRNA, [Carbon Tetrachloride co-treated with TM4SF4 protein] results in decreased expression of MET protein CTD PMID:17069928 tetrachloromethane multiple interactions ISO RGD:10894 6480464 Carbon Tetrachloride results in decreased phosphorylation of and results in decreased activity of MET protein, MET protein affects the reaction [Carbon Tetrachloride results in increased expression of SPP1 protein] CTD PMID:15070743 , PMID:17976157 tetrachloromethane increases expression ISO RGD:10894 6480464 Carbon Tetrachloride results in increased expression of MET mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MET mRNA CTD PMID:17009398 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of MET mRNA CTD PMID:25151969 thioacetamide affects methylation EXP 6480464 Thioacetamide affects the methylation of MET promoter CTD PMID:25151969 thymoquinone increases expression ISO RGD:10894 6480464 thymoquinone results in increased expression of MET mRNA CTD PMID:31812774 thymoquinone decreases expression ISO RGD:70824 6480464 thymoquinone results in decreased expression of MET mRNA CTD PMID:32112862 tienilic acid increases expression ISO RGD:70824 6480464 Ticrynafen results in increased expression of MET mRNA CTD PMID:32816093 titanium dioxide increases expression ISO RGD:10894 6480464 titanium dioxide results in increased expression of MET mRNA CTD PMID:23409001 tolcapone increases expression ISO RGD:70824 6480464 Tolcapone results in increased expression of MET mRNA CTD PMID:32816093 trazodone increases expression ISO RGD:70824 6480464 Trazodone results in increased expression of MET mRNA CTD PMID:32816093 triazines multiple interactions ISO RGD:10894 6480464 Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of MET mRNA] CTD PMID:27469509 trichloroethene multiple interactions ISO RGD:10894 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of MET protein] CTD PMID:15363585 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of MET gene CTD PMID:27618143 trichloroethene increases expression ISO RGD:10894 6480464 Trichloroethylene results in increased expression of MET mRNA CTD PMID:15363585 trichostatin A increases expression ISO RGD:70824 6480464 trichostatin A results in increased expression of MET mRNA CTD PMID:24935251 , PMID:26238599 triclosan increases expression ISO RGD:70824 6480464 Triclosan results in increased expression of MET mRNA CTD PMID:30510588 Trihexyphenidyl increases expression ISO RGD:70824 6480464 Trihexyphenidyl results in increased expression of MET mRNA CTD PMID:32816093 trimellitic anhydride decreases expression ISO RGD:10894 6480464 trimellitic anhydride results in decreased expression of MET mRNA CTD PMID:19042947 triptonide decreases expression ISO RGD:10894 6480464 triptonide results in decreased expression of MET mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:10894 6480464 troglitazone results in increased expression of MET mRNA CTD PMID:28973697 troglitazone increases expression ISO RGD:70824 6480464 Troglitazone results in increased expression of MET mRNA CTD PMID:32816093 Tungsten carbide multiple interactions ISO RGD:70824 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of MET mRNA CTD PMID:18078969 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of MET mRNA CTD PMID:11983124 valproic acid increases expression ISO RGD:70824 6480464 Valproic Acid results in increased expression of MET mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:70824 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MET mRNA CTD PMID:27188386 vemurafenib multiple interactions ISO RGD:70824 6480464 [MET protein affects the susceptibility to HGF protein] affects the reaction [[BRAF protein mutant form results in increased susceptibility to vemurafenib] which results in increased expression of BBC3 protein] more ... CTD PMID:27689874 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MET mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of MET mRNA CTD PMID:18220299 zafirlukast increases expression ISO RGD:70824 6480464 zafirlukast results in increased expression of MET mRNA CTD PMID:32816093 zearalenone increases expression ISO RGD:70824 6480464 Zearalenone results in increased expression of MET mRNA CTD PMID:19371625 zinc sulfate multiple interactions ISO RGD:10894 6480464 [Zinc Sulfate co-treated with HGF protein] results in increased phosphorylation of MET protein CTD PMID:22374166
